Kevin Feeley - 26 Mar 2024 Form 4 Insider Report for GeneDx Holdings Corp. (WGS)

Signature
/s/ Bridget Brown, Attorney-in-Fact
Issuer symbol
WGS
Transactions as of
26 Mar 2024
Net transactions value
-$398,767
Form type
4
Filing time
17 Mar 2025, 21:50:37 UTC
Previous filing
19 Mar 2024
Next filing
30 Apr 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WGS Class A Common Stock Sale $36,202 -402 -7.4% $90.05 5,044 13 Mar 2025 Direct F1
transaction WGS Class A Common Stock Options Exercise $0 -7,197 -37% $0.000000 12,241 16 Mar 2025 Direct
transaction WGS Class A Common Stock Sale $362,565 -3,749 -31% $96.71 8,492 17 Mar 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WGS Restricted Stock Unit Award $0 +65,000 $0.000000 65,000 26 Mar 2024 Class A Common Stock 65,000 Direct F3, F4
transaction WGS Restricted Stock Unit Award $0 +15,261 $0.000000 15,261 15 Mar 2025 Class A Common Stock 15,261 Direct F3, F5
transaction WGS Restricted Stock Unit Options Exercise $0 -7,197 -11% $0.000000 57,575 16 Mar 2025 Class A Common Stock 7,197 Direct F3, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sales were to satisfy tax withholding obligations to be funded by a "sell to cover" transaction
F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.67 to $96.71 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
F4 On March 26, 2024, Kevin Feeley was granted an RSU award for 65,000 RSUs. 25% of the underlying restricted stock units each vests annually, commencing on March 26, 2025, until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
F5 25% of the underlying restricted stock units each vests annually, commencing on March 15, 2026, until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
F6 6.25% vest in quarterly installments over the 4-year period commencing on March 16, 2023 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.